Gracell Biotechnologies Inc. (GRCL) Financial Ratios Annual - Discounting Cash Flows
GRCL
Gracell Biotechnologies Inc.
GRCL (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Price Ratios
Price to Earnings Ratio -1.59 -0.354 -1.08 -10.88 -5.23 -11.23
Price to Sales Ratio 0 0 1,379 0 0 0
Price to Book Ratio 0.702 0.156 0.276 2.62 2.71 286.4
Price to Free Cash Flow Ratio -1.89 -0.059 -1.4 -7.73 -3.6 -9.32
Price to Operating Cash Flow Ratio -0.292 -0.065 -1.66 -10.82 -5.1 -11.04
Price Earnings to Growth Ratio -0.016 -0.013 -0.008 0.198 -0.045 0
EV to EBITDA 3.01 2.15 3.05 3.24 1.23 -0.417
Liquidity Ratios
Current Ratio 6.78 6.78 12.15 8.73 18.74 17.2
Quick Ratio 6.78 6.78 12.1 8.73 18.22 16.16
Cash Ratio 6.59 6.59 11.79 8.08 17.18 1.6
Debt Ratio 0.11 0.11 0.075 0.107 0.336 0.934
Debt to Equity Ratio 0.133 0.133 0.085 0.126 0.543 58.2
Long Term Debt to Capitalization 0.037 0.037 0.036 0.06 0.352 0.983
Total Debt to Capitalization 0.117 0.117 0.078 0.112 0.352 0.983
Interest Coverage Ratio -92.72 -92.72 -91.56 -99.49 0 0
Cash Flow to Debt Ratio -18.07 -18.07 -1.96 -1.93 -0.976 -0.446
Margins
Gross Profit Margin 0% 0% 100% 0% 0% 0%
Operating Profit Margin 0% 0% -126,659% 0% 0% 0%
Pretax Profit Margin 0% 0% -123,430% 0% 0% 0%
Net Profit Margin 0% 0% -127,290% 0% 0% 0%
Operating Cash Flow Margin 0% 0% -83,210% 0% 0% 0%
Free Cash Flow Margin 0% 0% -98,714% 0% 0% 0%
Return
Return on Assets -36.68% -36.68% -22.61% -20.43% -32.06% -40.93%
Return on Equity -37.93% -44.16% -25.49% -24.05% -51.76% -2,551%
Return on Capital Employed -43.51% -43.51% -24.33% -24.6% -37.2% -44.3%
Return on Invested Capital 0% 0% -609.9% 0% 0% 0%
Turnover Ratios
Receivables Turnover Ratio 0 0 0 0 0 0
Payables Turnover Ratio 0 0 0 0 0 0
Inventory Turnover Ratio 0 0 0 0 0 0
Fixed Asset Turnover Ratio 0 0 0.002 0 0 0
Asset Turnover Ratio 0 0 0 0 0 0
Per Share Items ()
Revenue Per Share 0 0 0.028 0 0 0
Operating Cash Flow Per Share -244.2 -244.2 -23.15 -15.11 -34.17 -15.61
Free Cash Flow Per Share -268.7 -268.7 -27.47 -21.17 -48.42 -18.48
Cash & Short Term Investments 107.7 107.7 139.3 58.95 79.83 28.75
Earnings Per Share 0 0 -35.42 0 0 0
EBITDA Per Share -31.29 -43.76 -29.28 -15.77 -36.35 -15.02
Dividend Per Share 0 0 0 0 0 0
Enterprise Value Per Share -94.18 -94.18 -89.15 -51.11 -44.82 6.26
Book Value Per Share 0 0 138.9 0 0 0
Price Per Share 0 0 38.37 0 0 0
Effective Tax Rate -0.004% -0.004% 0% 6.96% 4.68% 0%
Short Term Coverage Ratio -25.44 -25.44 -3.54 -3.89 0 0
Capital Expenditure Coverage Ratio -9.97 -9.97 -5.37 -2.5 -2.4 -5.45
EBIT Per Revenue 0 0 -1,267 0 0 0
EBITDA Per Revenue None None -1,052 None None None
Days of Sales Outstanding 0 0 0 0 0 0
Days of Inventory Outstanding 0 0 0 0 0 0
Days of Payables Outstanding 0 0 0 0 0 0
Cash Conversion Cycle 0 0 0 0 0 0
Cash Conversion Ratio 0 0 0.654 0 0 0
Free Cash Flow to Earnings 0 0 0.776 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program